Harvard Bioscience | 10-Q: Q2 2024 Earnings Report
Harvard Bioscience | 8-K: Harvard Bioscience Announces Second Quarter 2024 Financial Results
Harvard Bioscience | 4: Statement of changes in beneficial ownership of securities-Officer Green James W
Harvard Bioscience | 4: Statement of changes in beneficial ownership of securities-Officer Green James W
Harvard Bioscience | SD: Specialized disclosure report
Harvard Bioscience | 4: Statement of changes in beneficial ownership of securities-Director LOY BERTRAND
Harvard Bioscience | 4: Statement of changes in beneficial ownership of securities-Director Eade Katherine A.
Harvard Bioscience | 4: Statement of changes in beneficial ownership of securities-Director Loewald Thomas W
Harvard Bioscience | 4: Statement of changes in beneficial ownership of securities-Director EDRICK ALAN I
Harvard Bioscience | 8-K: Current report
Harvard Bioscience | 10-Q: Q1 2024 Earnings Report
Harvard Bioscience | 8-K: Harvard Bioscience Announces First Quarter 2024 Financial Results
Harvard Bioscience | ARS: Annual Report to Security Holders
Harvard Bioscience | DEFA14A: Others
Harvard Bioscience | DEF 14A: Definitive information statements
Harvard Bioscience | 8-K: Current report
Harvard Bioscience | 8-K: Current report
Harvard Bioscience | SC 13G: Statement of acquisition of beneficial ownership by individuals-AMH Equity LLC(5.32%),Leviticus Partners, L.P.(5.32%)
Harvard Bioscience | 10-K: FY2023 Annual Report
Harvard Bioscience | 4: Statement of changes in beneficial ownership of securities-Officer Green James W
No Data
No Data